Rigel Pharmaceuticals Inc — Statistiche Finanziarie Trimestrali (NASDAQ:RIGL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 14.5 M-893 K30.54 M24.03 M21.98 M 75.66 M Flussi di cassa derivanti dalle attività di investimento -10.91 M-10.55 M-23.28 M-33.17 M-25.36 M -92.36 M Liquidità derivante dalle attività di finanziamento 1.47 M484 K418 K4.27 M-4.57 M 601 K Liquidità libera 14.5 M-893 K30.54 M24.03 M21.98 M 75.66 M

Notizie

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel Q4 2025: crescita annuale del 60%, dati promettenti su MDS

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates